Enanta Pharmaceuticals Inc. sell JPMorgan Chase & Co.
Start price
06.08.24
/
50%
€11.50
Target price
06.08.25
€9.15
Performance (%)
-47.83%
End price
07.08.25
€6.00
Summary
This prediction ended on 07.08.25 with a price of €6.00. JPMorgan_Chase___Co_ correctly predicted massive losses of -47.83% for Enanta Pharmaceuticals Inc.. JPMorgan_Chase___Co_ has a follow-up prediction for Enanta Pharmaceuticals Inc., but this time predicts that Enanta Pharmaceuticals Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | -1.887% | -1.887% | 98.095% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,04 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 13,43 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 23,57 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 8,65 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $10.00. They now have an "underweight" rating on the stock.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.60
14.11.25
14.11.25
€14.61
14.11.26
14.11.26
2.83%
27.03.26
27.03.26
Stopped prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
09.08.23
09.08.23
€12.75
09.08.24
09.08.24
-25.17%
10.08.24
10.08.24